A New Paradigm in Drug Development
The Vision
InSimili recreates the real human body microenvironment in vitro, enabling better decisions in pre-clinical studies and reducing in vivo testing.​ Helping develop new therapies more efficiently and safely.
Our Solution
Cells experience different oxygen availability in the body. Our technology regulates the concentration of oxygen and other agents at the microscale. Mimicking unique conditions found in patients in a standard consumable.
The Insimili Advantage
Our patented solution maintains a stable chemical microenvironment from cell culturing to imaging. It is standard compliant, cost-effective, and scalable. Unlocking the potential of testing in hypoxic conditions from high throughput screening to complex 3D models.
Who We Are
InSimili started in 2021 as a spin-off of the University of Bologna. Its proprietary technology was invented by professor Stefania Rapino group, and already used in prominent Italian research institutes.
Our Partners
Our Team
Enrico Grassilli, CEO
Previously Lead microfluidics Engineer at a biotech startup in Silicon Valley.
Marco Malferrari, PhD. CSO
Jr. Assistant professor at the University of Bologna. Expert in biology and cell cultures.
Prof. Stefania Rapino CTO
Associate Professor of Chemistryat the University of Bologna. Main inventor of the InSimili technology.